Pharmacokinetics, Safety and Tolerability of ITF2357 in Participants With Chronic Hepatic Impairment and With Normal Hepatic Function
Clinical trial NCT06736223 · COMPLETED
Trial details
- NCT number
- NCT06736223
- Sponsor
- Italfarmaco
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-29
- Primary completion
- 2025-08-14
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.